The Drug Pipeline: What’s In It & Why It Matters – May 2017

Today’s pipeline for new drugs bears witness to an era of research characterized by breakthrough therapies for relatively small patient populations. In most cases, these therapies dramatically prolong and improve the quality of life. Pricing for these drugs can also be described as “breakthrough,” and put growing pressure on pooling and stop-loss mechanisms, as well as cost-management measures for traditional drugs.

Download the article here

Previous New Strategic Partner: Medisys – June 2020